CCL2 and rheumatoid arthritis: In previous studies, MCP-1 levels in serum and synovial fluid of patients with rheumatoid arthritis were found to be significantly increased compared with that in healthy controls, and high levels of MCP-1 concentrated mononuclear cells from the blood to the articular cavity and then macrophages, activating downstream inflammatory responses and resulting in inflammatory injury [49–51].